Chloroquine Phosphate
6 NDCs across 4 manufacturers|6 Generic,0 Brand
Chloroquine Phosphate is used to treat amebiasis, rheumatoid arthritis, discoid lupus erythematosus, avian malaria, falciparum malaria and pemphigus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $400K on Chloroquine Phosphate across 3,472 claims for 1,683 beneficiaries.
Chloroquine Phosphate is available as 6 NDCs from 4 manufacturers (6 generic, 0 brand), with NADAC prices from $2.54 to $6.65 per EA — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
4
competing in market
Price Spread
$2.54 – $6.65
per EA
7d Activity
avg -1.4% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals of New York LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antimalarial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing CHLOROQUINE PHOSPHATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CHLOROQUINE PH 500 MG TABLET | $6.6539 per EA | -1.30% |
CHLOROQUINE PH 500 MG TABLET | $6.6539 per EA | -1.30% |
CHLOROQUINE PH 500 MG TABLET | $6.6539 per EA | -1.30% |
CHLOROQUINE PH 500 MG TABLET | $6.6539 per EA | -1.30% |
CHLOROQUINE PH 250 MG TABLET | $2.5396 per EA | -1.73% |
CHLOROQUINE PH 250 MG TABLET | $2.5396 per EA | -1.73% |
Frequently Asked Questions
What is Chloroquine Phosphate used to treat?
Chloroquine Phosphate is used to treat amebiasis, rheumatoid arthritis, discoid lupus erythematosus, avian malaria, falciparum malaria and pemphigus, per the National Library of Medicine's MED-RT classification.
When did Chloroquine Phosphate become available as a generic?
FDA approved the first generic Chloroquine Phosphate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Chloroquine Phosphate?
In 2024, Medicare Part D spent $400K on Chloroquine Phosphate across 3,472 claims for 1,683 beneficiaries.
How many Chloroquine Phosphate products are on the market?
The Chloroquine Phosphate drug market contains 6 NDCs from 4 manufacturers — 6 generic and 0 brand products.
What is the price range for Chloroquine Phosphate?
NADAC reference prices for Chloroquine Phosphate range from $2.5396 to $6.6539 per EA — the most expensive product costs about 2.6× the cheapest.
Which manufacturers make Chloroquine Phosphate?
4 manufacturers list Chloroquine Phosphate in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals of New York LLC (2), Rising Pharma Holdings Inc. (2), Avet Pharmaceuticals Inc. (1), Chartwell RX LLC (1).
How has the price of Chloroquine Phosphate changed recently?
Over the past 7 days, 0 Chloroquine Phosphate NDCs rose and 6 fell, with a market-wide average change of -1.4%.